These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 2317799)

  • 1. Prevention of fatal infections by recombinant human interleukin 1 alpha in normal and anticancer drug-treated mice.
    Morikage T; Mizushima Y; Sakamoto K; Yano S
    Cancer Res; 1990 Apr; 50(7):2099-104. PubMed ID: 2317799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemoprotective effects of recombinant human IL-1 alpha in cyclophosphamide-treated normal and tumor-bearing mice. Protection from acute toxicity, hematologic effects, development of late mortality, and enhanced therapeutic efficacy.
    Futami H; Jansen R; MacPhee MJ; Keller J; McCormick K; Longo DL; Oppenheim JJ; Ruscetti FW; Wiltrout RH
    J Immunol; 1990 Dec; 145(12):4121-30. PubMed ID: 2258610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin 18 induces the sequential activation of natural killer cells and cytotoxic T lymphocytes to protect syngeneic mice from transplantation with Meth A sarcoma.
    Micallef MJ; Tanimoto T; Kohno K; Ikeda M; Kurimoto M
    Cancer Res; 1997 Oct; 57(20):4557-63. PubMed ID: 9377569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved survival of lethally irradiated recipient mice transplanted with circulating progenitor cells mobilized by IL-8 after pretreatment with stem cell factor.
    Laterveer L; Zijlmans JM; Lindley IJ; Hamilton MS; Willemze R; Fibbe WE
    Exp Hematol; 1996 Oct; 24(12):1387-93. PubMed ID: 8913284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Augmentation of host defense against bacterial infection pretreated intraperitoneally with an alpha-glucan RBS in mice.
    Takeda Y; Yoshikai Y; Ohga S; Nomoto K
    Immunopharmacol Immunotoxicol; 1990; 12(3):457-77. PubMed ID: 2266231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of a traditional Chinese medicine, bu-zhong-yi-qi-tang (Japanese name: Hochu-ekki-to) on the protection against Listeria monocytogenes infection in mice.
    Li XY; Takimoto H; Miura S; Yoshikai Y; Matsuzaki G; Nomoto K
    Immunopharmacol Immunotoxicol; 1992; 14(3):383-402. PubMed ID: 1517527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of cytokines on polymorphonuclear neutrophil infiltration in the mouse. Prostaglandin- and leukotriene-independent induction of infiltration by IL-1 and tumor necrosis factor.
    Sayers TJ; Wiltrout TA; Bull CA; Denn AC; Pilaro AM; Lokesh B
    J Immunol; 1988 Sep; 141(5):1670-7. PubMed ID: 3261759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interdependence of the radioprotective effects of human recombinant interleukin 1 alpha, tumor necrosis factor alpha, granulocyte colony-stimulating factor, and murine recombinant granulocyte-macrophage colony-stimulating factor.
    Neta R; Oppenheim JJ; Douches SD
    J Immunol; 1988 Jan; 140(1):108-11. PubMed ID: 2447166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor effect of interleukin 7 in combination with local hyperthermia in mice bearing B16a melanoma cells.
    Wu B; Shen RN; Wang WX; Broxmeyer HE; Lu L
    Stem Cells; 1993 Sep; 11(5):412-21. PubMed ID: 8241952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined interleukin 1 beta/interleukin 2 treatment in mice: synergistic myelostimulatory activity and protection against cyclophosphamide-induced myelosuppression.
    Proietti E; Tritarelli E; Gabriele L; Testa U; Greco G; Pelosi E; Gabbianelli M; Belardelli F; Peschle C
    Cancer Res; 1993 Feb; 53(3):569-76. PubMed ID: 8425189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of mice with IL-1 before infection increases resistance to a lethal challenge with Salmonella typhimurium. The effect correlates with the resistance allele at the Ity locus.
    Morrissey PJ; Charrier K
    J Immunol; 1994 Jul; 153(1):212-9. PubMed ID: 8207237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of in vivo administration of IL-3 and IL-6, alone and in combination with G-CSF, GM-CSF or IL-1, on haematopoiesis, graft-versus-host disease and survival after murine haematopoietic stem cell transplantation.
    Atkinson K; Vos B; Kang-Er Z; Guiffre A; Seymour R; Gillis S
    Cytokines Mol Ther; 1995 Mar; 1(1):47-55. PubMed ID: 9384663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of murine recombinant interleukin 1 alpha on the host response to bacterial infection.
    Czuprynski CJ; Brown JF; Young KM; Cooley AJ; Kurtz RS
    J Immunol; 1988 Feb; 140(3):962-8. PubMed ID: 2448381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous IL-10 leads to impaired bacterial clearance and reduced survival in a murine model of chronic peritonitis.
    Lenz AM; Franklin GA; Fairweather M; McClintock ML; Jala VR; Peyton JC; Gardner SA; Cheadle WG
    Cytokine; 2007 Dec; 40(3):207-15. PubMed ID: 18053738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined interleukin-1 beta/interleukin-6 treatment in mice: synergistic myelostimulatory activity and myelorestorative effect after cyclophosphamide-induced myelosuppression.
    Tritarelli E; Greco G; Testa U; Belardelli F; Peschle C; Proietti E
    Cancer Res; 1994 Dec; 54(24):6469-76. PubMed ID: 7987845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of in vivo administration of anti-IL-10 monoclonal antibody on the host defence mechanism against murine Salmonella infection.
    Arai T; Hiromatsu K; Nishimura H; Kimura Y; Kobayashi N; Ishida H; Nimura Y; Yoshikai Y
    Immunology; 1995 Jul; 85(3):381-8. PubMed ID: 7558125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of continuous administration of interleukin 2 on active specific chemoimmunotherapy with extracted tumor-specific transplantation antigen and cyclophosphamide.
    Naito K; Pellis NR; Kahan BD
    Cancer Res; 1988 Jan; 48(1):101-8. PubMed ID: 3257158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effects of recombinant human interleukin-1 alpha in doxorubicin-treated normal and tumor-bearing mice.
    Lynch DH; Rubin AS; Miller RE; Williams DE
    Cancer Res; 1993 Apr; 53(7):1565-70. PubMed ID: 8453624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential gene expression for IL-1 receptor antagonist, IL-1, and TNF receptors and IL-1 and TNF synthesis may explain IL-1-induced resistance to infection.
    Vogels MT; Mensink EJ; Ye K; Boerman OC; Verschueren CM; Dinarello CA; van der Meer JW
    J Immunol; 1994 Dec; 153(12):5772-80. PubMed ID: 7989774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Limulus anti-LPS factor-derived peptide modulates cytokine gene expression and promotes resolution of bacterial acute infection in mice.
    Vallespi MG; Alvarez-Obregón JC; Rodriguez-Alonso I; Montero T; Garay H; Reyes O; Araña MJ
    Int Immunopharmacol; 2003 Feb; 3(2):247-56. PubMed ID: 12586605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.